- Home
- Publications
- Publication Search
- Publication Details
Title
Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-06-19
DOI
10.3389/fimmu.2018.01412
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine
- (2018) Prakash P. Praharaj et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System
- (2018) Christina Wefers et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hitting the Target: How T Cells Detect and Eliminate Tumors
- (2018) Anthony E. Zamora et al. JOURNAL OF IMMUNOLOGY
- Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
- (2018) Georgios Vlachogiannis et al. SCIENCE
- Dendritic cells as cancer therapeutics
- (2018) Christian E. Bryant et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Cancer stem cells as targets for immunotherapy
- (2017) Amy S. Codd et al. IMMUNOLOGY
- PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation
- (2017) Sheema Almozyan et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer Stem Cell–Related Marker NANOG Expression in Ovarian Serous Tumors
- (2017) Nataša Kenda Šuster et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Biomaterials to suppress cancer stem cells and disrupt their tumoral niche
- (2017) Carla Garcia-Mazas et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Contributions of 3D Cell Cultures for Cancer Research
- (2017) Maddaly Ravi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Subcellular localisation of the stem cell markers OCT4, SOX2, NANOG, KLF4 and c-MYC in cancer: a review
- (2017) Bede van Schaijik et al. JOURNAL OF CLINICAL PATHOLOGY
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- Human tissues in a dish: The research and ethical implications of organoid technology
- (2017) Annelien L. Bredenoord et al. SCIENCE
- The dark side of SOX2: cancer - a comprehensive overview
- (2017) Erin L. Wuebben et al. Oncotarget
- Umbilical cord blood CD34+ progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rgnull mice
- (2017) Janneke S. Hoogstad-van Evert et al. OncoImmunology
- Cancer Stem Cells: Basic Concepts and Therapeutic Implications
- (2016) Dany Nassar et al. Annual Review of Pathology-Mechanisms of Disease
- Silencing expression of the NANOG gene and changes in migration and metastasis of urinary bladder cancer cells
- (2016) Natalia Gawlik-Rzemieniewska et al. Archives of Medical Science
- Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancer
- (2016) Fang Ren et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Rejection versus escape: the tumor MHC dilemma
- (2016) Federico Garrido et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Roles of OCT4 in tumorigenesis, cancer therapy resistance and prognosis
- (2016) Emilly Schlee Villodre et al. CANCER TREATMENT REVIEWS
- Modeling Development and Disease with Organoids
- (2016) Hans Clevers CELL
- The urgent need to recover MHC class I in cancers for effective immunotherapy
- (2016) Federico Garrido et al. CURRENT OPINION IN IMMUNOLOGY
- Immune suppressive mechanisms in the tumor microenvironment
- (2016) David H Munn et al. CURRENT OPINION IN IMMUNOLOGY
- Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells
- (2016) Wen-Shin Song et al. Journal of the Chinese Medical Association
- Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma
- (2016) Itay Tirosh et al. NATURE
- Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer
- (2016) A E Witt et al. ONCOGENE
- What Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer Tissue
- (2016) Komal Qureshi-Baig et al. PLoS One
- Tumoral reprogramming: Plasticity takes a walk on the wild side
- (2015) Elena Campos-Sánchez et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition
- (2015) Fumiyuki Sato et al. CANCER BIOLOGY & THERAPY
- The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells
- (2015) Natalia Gawlik-Rzemieniewska et al. CANCER BIOLOGY & THERAPY
- Immunotherapy with dendritic cells loaded with glioblastoma stem cells: from preclinical to clinical studies
- (2015) Gaetano Finocchiaro et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune responses to human cancer stem-like cells/cancer-initiating cells
- (2015) Yoshihiko Hirohashi et al. CANCER SCIENCE
- NANOG signaling promotes metastatic capability of immunoedited tumor cells
- (2015) Hyo-Jung Lee et al. CLINICAL & EXPERIMENTAL METASTASIS
- Food systems approach to cancer prevention
- (2015) Jairam Vanamala CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Stem cell transcription factor NANOG in cancers – is eternal youth a curse?
- (2015) Oscar GW Wong et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- mRNA detection in living cells: A next generation cancer stem cell identification technique
- (2015) Steven McClellan et al. METHODS
- Regulation of NANOG in cancer cells
- (2015) Shuai Gong et al. MOLECULAR CARCINOGENESIS
- Targeting LGR5 + cells with an antibody-drug conjugate for the treatment of colon cancer
- (2015) Melissa R. Junttila et al. Science Translational Medicine
- A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
- (2015) Laura R. Saunders et al. Science Translational Medicine
- YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate Self-Renewal and Vascular Mimicry of Stem-Like Cells
- (2015) Namrata Bora-Singhal et al. STEM CELLS
- Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells
- (2015) Se Jin Oh et al. Oncotarget
- CRISPR/Cas9-mediated gene knockout of NANOG and NANOGP8 decreases the malignant potential of prostate cancer cells
- (2015) Norihiko Kawamura et al. Oncotarget
- Eradicating cancer cells: struggle with a chameleon
- (2015) Jiabo Di et al. Oncotarget
- TALEN-mediated Nanog disruption results in less invasiveness, more chemosensitivity and reversal of EMT in Hela cells
- (2015) Yan Ding et al. Oncotarget
- Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin
- (2015) King Chi Chan et al. Scientific Reports
- Epigenetics in acute promyelocytic leukaemia pathogenesis and treatment response: A TRAnsition to targeted therapies
- (2014) M F Arteaga et al. BRITISH JOURNAL OF CANCER
- Targeting cancer stem cells by curcumin and clinical applications
- (2014) Yanyan Li et al. CANCER LETTERS
- Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy
- (2014) B Auffinger et al. CELL DEATH AND DIFFERENTIATION
- Observation of ovarian cancer stem cell behavior and investigation of potential mechanisms of drug resistance in three-dimensional cell culture
- (2014) Junsong Chen et al. JOURNAL OF BIOSCIENCE AND BIOENGINEERING
- NanoFlares for the detection, isolation, and culture of live tumor cells from human blood
- (2014) Tiffany L. Halo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Organogenesis in a dish: Modeling development and disease using organoid technologies
- (2014) M. A. Lancaster et al. SCIENCE
- Transcription factor decoy against stem cells master regulators, Nanog and Oct-4: a possible approach for differentiation therapy
- (2014) Seyed Mohammad Ali Hosseini Rad et al. TUMOR BIOLOGY
- Location, location, location
- (2014) John R Webb et al. OncoImmunology
- Postdiagnosis Cruciferous Vegetable Consumption and Breast Cancer Outcomes: A Report from the After Breast Cancer Pooling Project
- (2013) S. Nechuta et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Cancer stem cells: The challenges ahead
- (2013) Jan Paul Medema NATURE CELL BIOLOGY
- Sulforaphane: translational research from laboratory bench to clinic
- (2013) Christine A Houghton et al. NUTRITION REVIEWS
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Targeting cancer stem cells: emerging role of Nanog transcription factor
- (2013) Cheng-Wen (Ken) Wu et al. OncoTargets and Therapy
- Effect of shRNA-mediated inhibition of Nanog gene expression on the behavior of human gastric cancer cells
- (2013) WEN JI et al. Oncology Letters
- The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients
- (2013) Jiabo Di et al. CELLULAR ONCOLOGY
- NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128
- (2013) R Nanta et al. Oncogenesis
- Functional OCT4-specific CD4+and CD8+T cells in healthy controls and ovarian cancer patients
- (2013) Jiabo Di et al. OncoImmunology
- Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
- (2012) Subash C. Gupta et al. AAPS Journal
- RNA interference-mediated silencing of NANOG reduces cell proliferation and induces G0/G1 cell cycle arrest in breast cancer cells
- (2012) Jinghua Han et al. CANCER LETTERS
- Cancer Vaccination Drives Nanog-Dependent Evolution of Tumor Cells toward an Immune-Resistant and Stem-like Phenotype
- (2012) K. H. Noh et al. CANCER RESEARCH
- Cancer Stem Cells and Novel Targets for Antitumor Strategies
- (2012) Gerald J. Prud’homme CURRENT PHARMACEUTICAL DESIGN
- Nanog signaling in cancer promotes stem-like phenotype and immune evasion
- (2012) Kyung Hee Noh et al. JOURNAL OF CLINICAL INVESTIGATION
- Isothiocyanate concentrations and interconversion of sulforaphane to erucin in human subjects after consumption of commercial frozen broccoli compared to fresh broccoli
- (2012) Shikha Saha et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
- (2012) Aleksandar Sekulic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers
- (2012) M K Y Siu et al. ONCOGENE
- Plasma Indoleamine 2,3-Dioxygenase and Arginase Type I May Contribute to Decreased Blood T-Cell Count in Hemodialysis Patients
- (2012) Theodoros Eleftheriadis et al. RENAL FAILURE
- Do cancer cells undergo phenotypic switching? The case for imperfect cancer stem cell markers
- (2012) Stefano Zapperi et al. Scientific Reports
- Strategies to counteract MHC-I defects in tumors
- (2011) Margit H Lampen et al. CURRENT OPINION IN IMMUNOLOGY
- Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
- (2011) Toshiro Sato et al. GASTROENTEROLOGY
- Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas
- (2011) Yuji Guo et al. HISTOPATHOLOGY
- Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
- (2011) Maryam Fouladi et al. JOURNAL OF CLINICAL ONCOLOGY
- Strength of TCR-Peptide/MHC Interactions and In Vivo T Cell Responses
- (2011) E. Corse et al. JOURNAL OF IMMUNOLOGY
- Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma
- (2011) Lo-Lin Tsai et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms
- (2011) Brahma N. Singh et al. PLoS One
- NANOG Has a Role in Mesenchymal Stem Cells' Immunomodulatory Effect
- (2011) Zhao Sun et al. STEM CELLS AND DEVELOPMENT
- Coexpression of Oct4 and Nanog Enhances Malignancy in Lung Adenocarcinoma by Inducing Cancer Stem Cell-Like Properties and Epithelial-Mesenchymal Transdifferentiation
- (2010) S.-H. Chiou et al. CANCER RESEARCH
- The role of tumor initiating cells in drug resistance of breast cancer: Implications for future therapeutic approaches
- (2010) Lara Lacerda et al. DRUG RESISTANCE UPDATES
- Ovarian cancer creates a suppressive microenvironment to escape immune elimination
- (2010) Refika Yigit et al. GYNECOLOGIC ONCOLOGY
- Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma
- (2010) Shidou Zhao et al. JOURNAL OF PATHOLOGY
- Natural immunity to pluripotency antigen OCT4 in humans
- (2010) K. M. Dhodapkar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Spheroid-based drug screen: considerations and practical approach
- (2009) Juergen Friedrich et al. Nature Protocols
- Molecular Characterization of the Human NANOG Protein
- (2009) David F. Chang et al. STEM CELLS
- CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
- (2008) L M Smith et al. BRITISH JOURNAL OF CANCER
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- NetMHCpan, a method for MHC class I binding prediction beyond humans
- (2008) Ilka Hoof et al. IMMUNOGENETICS
- New dimensions in tumor immunology: what does 3D culture reveal?
- (2008) Chantal Feder-Mengus et al. TRENDS IN MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More